DunhillTP. 1937. The Lettsomian lectures. The surgery of the thyroid gland. Trans Med Soc London, 60:234–282.
2.
CrileGJr. 1957. The endocrine dependency of certain thyroid cancers and the danger that hypothyroidism may stimulate their growth. Cancer, 10:1119–1137.
3.
GreerMA, AstwoodEB. 1953. Treatment of simple goiter with thyroid. J Clin Endocrinol Metab, 13:1312–1331.
4.
von EiselbergAF. 1894. Ueber physiologische Function einer im Sternum zur Entvicklung gekommen krebsigen Schilddrüsen-Metastase. Arch Klin Chir, 48:489–501.
5.
MeansJH. 1948. The relations of the thyroid to its endocrine partners. The Thyroid and Its Diseases, 2nd. JB Lippincott Co.: Philadelphia, 82–94.
6.
FrantzVK, BallRP, KestonAS, PalmerWW. 1944. Thyroid carcinoma with metastases: studied with radioactive iodine. Ann Surg, 119:668–689.
7.
SeidlinSM, OshryBS, YalowAA. 1948. Spontaneous and experimentally induced uptake of radioactive iodine in metastases from thyroid carcinoma: a preliminary report. J Clin Endocrinol, 8:423–432.
8.
RawsonRW, MarinelliLD, SkanseBN, TrunnellJ, FluhartyRG. 1948. The effect of total thyroidectomy on the function of metastatic thyroid cancer. J Clin Endocrinol, 8:826–841.
9.
MaloofF, VickeryA, RappB. 1956. An evaluation of various factors influencing the treatment of metastatic thyroid carcinoma with I-131. J Clin Endocrinol Metab, 16:1–27.
10.
GreerMA. 1951. The effect on endogenous thyroid activity of feeding desiccated thyroid to normal human subjects. N Engl J Med, 244:385–390.
11.
BalmeHW. 1954. Metastatic carcinoma of the thyroid successfully treated with thyroxine. Lancet, 1:812–813.
12.
CrileGJr. 1955. Treatment of cancer of the thyroid with desiccated thyroid. Cleve Clin Q, 22:161–163.
13.
CrileGJr. 1966. Endocrine dependency of papillary carcinomas of the thyroid. JAMA, 195:101–104.
14.
CrileGJr, AntunezAR, EsselstynCBJr, HawkWA, SkillernPG. 1985. The advantages of subtotal thyroidectomy and suppression of TSH in the primary treatment of papillary carcinoma of the thyroid. Cancer, 55:2691–2697.
15.
CrileGJr. 1988. A second opinion about thyroid hormone treatment. Surgery, 103:268–269.
ThomasCGJr. 1991. Role of thyroid stimulating hormone suppression in the management of thyroid cancer. Semin Surg Oncol, 7:115–119.
18.
BiondiB, CooperDS. 2010. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid, 20:135–146.
19.
MazzaferriEL, YoungRL, OertelJE, KemmererWT, PageCP. 1977. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine, 56:171–196.
20.
MazzaferriEL, JhiangSM. 1994. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 97:418–428.
21.
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. CooperDS, DohertyGM, HaugenBR, KloosRT, LeeSL, MandelSJ, MazzaferriEL, McIverB, PaciniF, SchlumbergerM, ShermanSI, StewardDL, TuttleRM. 2009. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid. cancer, 19:1167–1214.
